KR100625146B1 - 모르폴리노 에테르 - Google Patents

모르폴리노 에테르 Download PDF

Info

Publication number
KR100625146B1
KR100625146B1 KR1020007012581A KR20007012581A KR100625146B1 KR 100625146 B1 KR100625146 B1 KR 100625146B1 KR 1020007012581 A KR1020007012581 A KR 1020007012581A KR 20007012581 A KR20007012581 A KR 20007012581A KR 100625146 B1 KR100625146 B1 KR 100625146B1
Authority
KR
South Korea
Prior art keywords
methyl
straight
compound
substituted
formyl
Prior art date
Application number
KR1020007012581A
Other languages
English (en)
Korean (ko)
Other versions
KR20010025009A (ko
Inventor
호세에메. 부에노
헤수스 치차로곤잘로
호세-미구엘 꼬떼론
후안까를로스 꾸에바스
호세에메. 삐안도르
아라셀리 말로
Original Assignee
글락소 웰컴 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 글락소 웰컴 에스.에이. filed Critical 글락소 웰컴 에스.에이.
Publication of KR20010025009A publication Critical patent/KR20010025009A/ko
Application granted granted Critical
Publication of KR100625146B1 publication Critical patent/KR100625146B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR1020007012581A 1998-05-11 1999-05-07 모르폴리노 에테르 KR100625146B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98500117 1998-05-11
EP98500117.1 1998-05-11
EP98500204.7 1998-09-18
EP98500204 1998-09-18

Publications (2)

Publication Number Publication Date
KR20010025009A KR20010025009A (ko) 2001-03-26
KR100625146B1 true KR100625146B1 (ko) 2006-09-20

Family

ID=26151831

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007012581A KR100625146B1 (ko) 1998-05-11 1999-05-07 모르폴리노 에테르

Country Status (13)

Country Link
EP (1) EP1077959A1 (tr)
JP (1) JP2002514632A (tr)
KR (1) KR100625146B1 (tr)
CN (1) CN1174971C (tr)
AR (1) AR016261A1 (tr)
AU (1) AU763088B2 (tr)
BR (1) BR9910377A (tr)
CA (1) CA2331584A1 (tr)
MA (1) MA26628A1 (tr)
PE (1) PE20000479A1 (tr)
TR (1) TR200003301T2 (tr)
TW (1) TW585858B (tr)
WO (1) WO1999058512A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286208A1 (en) * 2000-09-13 2002-03-26 Sankyo Company Limited Zofimarin derivatives having oxazepam ring
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
EP3252043B1 (en) * 2015-01-30 2020-09-30 NOF Corporation Cationic lipid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711783A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
AU704405B2 (en) * 1994-11-08 1999-04-22 Glaxo Wellcome S.A. Antifungal sordaridin derivatives
EP0712859A1 (en) * 1994-11-08 1996-05-22 Glaxo, S.A. Antifungal Sordarin derivatives
EP0711784A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives
US6177457B1 (en) * 1996-05-08 2001-01-23 Glaxo Wellcome S.A. Process for the preparation of indacene compound
EP0938307B1 (en) * 1996-09-18 2003-05-07 Merck & Co., Inc. Sordarin and derivatives thereof for use as crop antifungal agents
WO1998015178A1 (en) * 1996-10-07 1998-04-16 Merck & Co., Inc. Sordarin derivatives
JP4339505B2 (ja) * 1997-08-22 2009-10-07 メルク エンド カムパニー インコーポレーテッド ４−シアノ−４−デホルミルソルダリン誘導体
HUP0002958A3 (en) * 1997-08-22 2001-02-28 Merck & Co Inc Fungicidal 4-cyano-4-deformyl-sordaricin derivatives, pharmaceutical and agricultural compositions containing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711783A1 (en) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungal Sordarin derivatives

Also Published As

Publication number Publication date
BR9910377A (pt) 2001-01-16
CA2331584A1 (en) 1999-11-18
PE20000479A1 (es) 2000-05-29
TW585858B (en) 2004-05-01
AU4258899A (en) 1999-11-29
TR200003301T2 (tr) 2001-02-21
CN1174971C (zh) 2004-11-10
AR016261A1 (es) 2001-06-20
WO1999058512A1 (en) 1999-11-18
KR20010025009A (ko) 2001-03-26
EP1077959A1 (en) 2001-02-28
JP2002514632A (ja) 2002-05-21
MA26628A1 (fr) 2004-12-20
AU763088B2 (en) 2003-07-10
CN1309651A (zh) 2001-08-22

Similar Documents

Publication Publication Date Title
TWI224593B (en) Renin inhibitors
US7053110B2 (en) Heterocyclic aromatic compounds useful as growth hormone secreagogues
US11352363B1 (en) Spiropyrrolidine derived antiviral agents
UA81276C2 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases, pharmaceutical preparation
JPH04505608A (ja) 非ペプチド系レニン阻害剤
US20220024941A1 (en) Preparation Method for Amide Compounds and Use Thereof in Medical Field
JPS6144868B2 (tr)
SE441449B (sv) Heterocykliska derivat och farmaceutiska kompositioner innehallande dessa derivat
KR100625146B1 (ko) 모르폴리노 에테르
KR900006128B1 (ko) N-[6-메톡시-5-(퍼플루오로알킬)-1-나프토일]-n-메틸글리신 및 이의 티오나프토일 동족체의 제조방법
US9670247B2 (en) Contraceptive agents
US4876281A (en) Antifungal agents
US20200016159A1 (en) N3-cyclically substituted thienouracils and use thereof
WO2004017995A1 (ja) 掻痒の予防および／または治療剤
JP2941333B2 (ja) インドール誘導体
SK227192A3 (en) Cyclohexane a tetrahydropyrane derivatives, methods of their production and pharmaceutical agent containing it
US6410528B1 (en) Morpholino ethers
US4526960A (en) Anthracycline glycosides
JP2001502313A (ja) ソルダリン誘導体
US6645960B1 (en) Antifungal sordaricin derivatives
WO1998011103A1 (en) New pharmaceutically active compounds
US20050004189A1 (en) Thiazole compounds as integrin receptor antagonists derivatives
HU216789B (hu) Eljárás hidrogénezett ciklopenta-piridin-tetrol alfa-mannozidáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények előállítására
JP2001513554A (ja) ４−シアノ−４−デホルミルソルダリシン誘導体
MXPA00010776A (en) Morpholino ethers

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee